Human body fluid proteome analysis

被引:406
作者
Hu, Shen
Loo, Joseph A.
Wong, David T.
机构
[1] Univ Calif Los Angeles, Div Oral Biol & Med, Sch Dent, Dent Res Inst, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
关键词
clinical proteomics; disease biomarkers; human body fluids; mass spectrometry;
D O I
10.1002/pmic.200600284
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The focus of this article is to review the recent advances in proteome analysis of human body fluids, including plasma/serum, urine, cerebrospinal fluid, saliva, bronchoalveolar lavage fluid, synovial fluid, nipple aspirate fluid, tear fluid, and amniotic fluid, as well as its applications to human disease biomarker discovery. We aim to summarize the proteomics technologies currently used for global identification and quantification of body fluid proteins, and elaborate the putative biomarkers discovered for a variety of human diseases through human body fluid proteome (HBFP) analysis. Some critical concerns and perspectives in this emerging field are also discussed. With the advances made in proteomics technologies, the impact of HBFP analysis in the search for clinically relevant disease biomarkers would be realized in the future.
引用
收藏
页码:6326 / 6353
页数:28
相关论文
共 478 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]   Data management and preliminary data analysis in the pilot phase of the HUPO Plasma Proteome Project [J].
Adamski, M ;
Blackwell, T ;
Menon, R ;
Martens, L ;
Hermjakob, H ;
Taylor, C ;
Omenn, GS ;
States, DJ .
PROTEOMICS, 2005, 5 (13) :3246-3261
[3]   Toward a human blood serum proteome - Analysis by multidimensional separation coupled with mass spectrometry [J].
Adkins, JN ;
Varnum, SM ;
Auberry, KJ ;
Moore, RJ ;
Angell, NH ;
Smith, RD ;
Springer, DL ;
Pounds, JG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (12) :947-955
[4]   A proteomic study of the HUPO Plasma Proteome Project's pilot samples using an accurate mass and time tag strategy [J].
Adkins, JN ;
Monroe, ME ;
Auberry, KJ ;
Shen, YF ;
Jacobs, JM ;
Camp, DG ;
Vitzthum, F ;
Rodland, KD ;
Zangar, RC ;
Smith, RD ;
Pounds, JG .
PROTEOMICS, 2005, 5 (13) :3454-3466
[5]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[6]   Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer [J].
Ahmed, N ;
Barker, G ;
Oliva, KT ;
Hoffmann, P ;
Riley, C ;
Reeve, S ;
Smith, AL ;
Kemp, BE ;
Quinn, MA ;
Rice, GE .
BRITISH JOURNAL OF CANCER, 2004, 91 (01) :129-140
[7]   An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum [J].
Ahmed, N ;
Barker, G ;
Oliva, K ;
Garfin, D ;
Talmadge, K ;
Georgiou, H ;
Quinn, M ;
Rice, G .
PROTEOMICS, 2003, 3 (10) :1980-1987
[8]   Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study [J].
Albrethsen, J ;
Bogebo, R ;
Gammeltoft, S ;
Olsen, J ;
Winther, B ;
Raskov, H .
BMC CANCER, 2005, 5 (1)
[9]   Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid [J].
Alexander, H ;
Stegner, AL ;
Wagner-Mann, C ;
Du Bois, GC ;
Alexander, S ;
Sauter, ER .
CLINICAL CANCER RESEARCH, 2004, 10 (22) :7500-7510
[10]   ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke [J].
Allard, L ;
Lescuyer, P ;
Burgess, J ;
Leung, KY ;
Ward, M ;
Walter, N ;
Burkhard, PR ;
Corthals, G ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2004, 4 (08) :2242-2251